Literature DB >> 11555072

Polymorphic variation in the human myostatin (GDF-8) gene and association with strength measures in the Women's Health and Aging Study II cohort.

M J Seibert1, Q L Xue, L P Fried, J D Walston.   

Abstract

OBJECTIVES: To determine whether polymorphic variation in the myostatin gene differentially influences the maintenance of muscle strength in older adults, and to find supportive evidence in a cohort of older women.
DESIGN: Correlation study of polymorphic variation in a cohort of older women.
SETTING: Representatively sampled older female population living in the eastern half of Baltimore, Maryland. PARTICIPANTS: Participants were 286 women, age 70 to 79. Of these, 81.1% were Caucasian, 18.8% were African American, and 0.2% were Asian or Hispanic. MEASUREMENTS: Overall strength was measured with a dynamometer and defined as the sum of the strongest measures of hip, knee, and grip strength on the dominant side.
RESULTS: We identified or confirmed six myostatin polymorphic variants in the Women's Health and Aging Study II population. Of the polymorphisms, K153R is the most common, with an allele frequency of 0.19 in African Americans. Unadjusted mean strength by genotype suggested lower muscle strength in those African-American women with the R genotype compared with those with the K genotype (K/K: 72.50 +/- 13.9 kg (n = 39) vs K/R: 67.14 +/- 11.4 kg (n = 13) vs R/R: 63.1 +/- 11.3 kg (n = 3)). After adjustment for race in a linear regression model, the R genotype remained associated with lower strength levels (P = .04). Statistical significance decreased when body mass index and race were both added to the model (P = .09).
CONCLUSIONS: Recognizing that small sample size in the study of genes of modest effect are unlikely to yield significant differences, these data suggest an association of the R153 allele with lower strength in high-functioning older women, which should be studied further in a larger cohort.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11555072     DOI: 10.1046/j.1532-5415.2001.49214.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  26 in total

1.  The K153R variant in the myostatin gene and sarcopenia at the end of the human lifespan.

Authors:  Marta González-Freire; Gabriel Rodríguez-Romo; Catalina Santiago; Natalia Bustamante-Ara; Thomas Yvert; Félix Gómez-Gallego; José A Serra Rexach; Jonatan R Ruiz; Alejandro Lucia
Journal:  Age (Dordr)       Date:  2010-03-23

Review 2.  Genes and human elite athletic performance.

Authors:  Daniel G Macarthur; Kathryn N North
Journal:  Hum Genet       Date:  2005-02-22       Impact factor: 4.132

Review 3.  Genetic aspects of skeletal muscle strength and mass with relevance to sarcopenia.

Authors:  Stephen M Roth
Journal:  Bonekey Rep       Date:  2012-04-04

Review 4.  Molecular genetic studies of gene identification for sarcopenia.

Authors:  Li-Jun Tan; Shan-Lin Liu; Shu-Feng Lei; Christopher J Papasian; Hong-Wen Deng
Journal:  Hum Genet       Date:  2011-06-26       Impact factor: 4.132

Review 5.  Genes and the ageing muscle: a review on genetic association studies.

Authors:  Nuria Garatachea; Alejandro Lucía
Journal:  Age (Dordr)       Date:  2011-10-27

Review 6.  Myostatin--the holy grail for muscle, bone, and fat?

Authors:  B Buehring; N Binkley
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096

7.  Is there an optimum endurance polygenic profile?

Authors:  Jonatan R Ruiz; Félix Gómez-Gallego; Catalina Santiago; Marta González-Freire; Zoraida Verde; Carl Foster; Alejandro Lucia
Journal:  J Physiol       Date:  2009-02-23       Impact factor: 5.182

8.  Exploration of myostatin polymorphisms and the angiotensin-converting enzyme insertion/deletion genotype in responses of human muscle to strength training.

Authors:  Martine A I Thomis; Wim Huygens; Sofie Heuninckx; Monique Chagnon; Hermine H M Maes; Albrecht L Claessens; Robert Vlietinck; Claude Bouchard; Gaston P Beunen
Journal:  Eur J Appl Physiol       Date:  2004-04-09       Impact factor: 3.078

Review 9.  Optimal management of sarcopenia.

Authors:  Louise A Burton; Deepa Sumukadas
Journal:  Clin Interv Aging       Date:  2010-09-07       Impact factor: 4.458

Review 10.  Effects of resistance training on older adults.

Authors:  Gary R Hunter; John P McCarthy; Marcas M Bamman
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.